Evolution Of the Treatment of Diabetic Retinopathy: From Past to Future
Keywords:
Diabetic Retinopathy, teleophthalmology, corticosteroid, therapieAbstract
This article provides a comprehensive overview of the historical development, current practices, and future directions in the treatment of diabetic retinopathy (DR), a major microvascular complication of diabetes mellitus and a leading cause of vision loss globally. Initially, treatment approaches focused on laser photocoagulation, which helped to stabilize vision but had limited potential for visual improvement and often came with significant side effects. Over time, the introduction of intravitreal pharmacotherapy, particularly anti-VEGF (vascular endothelial growth factor) agents, revolutionized the management of diabetic macular edema and proliferative diabetic retinopathy, offering improved outcomes in preserving and restoring vision.
The article also explores the role of corticosteroids, combination therapies, and vitrectomy for advanced cases. Emphasis is placed on recent innovations such as sustained-release drug implants, personalized medicine, and imaging technologies (like OCT and AI-assisted diagnostics) that enhance early detection and monitoring. Looking ahead, the article discusses emerging treatments including gene therapy, regenerative medicine using stem cells, and the potential application of artificial intelligence in predictive analytics and teleophthalmology.
By tracing the evolution of therapeutic strategies, the article highlights the significant progress in DR management and underscores the importance of integrating novel biomedical technologies to improve patient outcomes in the future
Downloads
References
American Diabetes Association. (2020). "Standards of Medical Care in Diabetes—2020." Diabetes Care, 43(Supplement 1), S1-S212. doi:10.2337/dc20-S001.
Liew, G., & Mitchell, P. (2003). "Diabetic retinopathy: The role of glucose control." Clinical & Experimental Ophthalmology, 31(5), 384-389. doi:10.1046/j.1442-9071.2003.00745.x.
Early Treatment Diabetic Retinopathy Study Research Group. (1985). "Photocoagulation for Diabetic Macular Edema. ETDRS Report No. 1." Archives of Ophthalmology, 103(12), 1796-1806. doi:10.1001/archopht.1985.01050120014002.
Ricci, F., & Neri, P. (2012). "Laser treatment of diabetic retinopathy: An update." Middle East African Journal of Ophthalmology, 19(3), 191-196. doi:10.4103/0974-9233.98679.
Fraser-Bell, S., & Kuppermann, B. D. (2005). "Corticosteroids in Diabetic Macular Edema." Journal of Ophthalmology, 93(7), 811-816. doi:10.1016/j.ophtha.2005.01.026.
Brown, D. M., & Kaiser, P. K. (2006). "Ranibizumab for diabetic macular edema: The RESTORE study." Ophthalmology, 113(3), 434-441. doi:10.1016/j.ophtha.2005.09.038.
American Academy of Ophthalmology. (2020). "Anti-VEGF Therapy in Diabetic Retinopathy." American Academy of Ophthalmology. Retrieved from https://www.aao.org.Sadda, S. R., & Vavvas, D. G. (2019). "OCT Angiography in Diabetic Retinopathy: An Emerging Tool." Ophthalmology, 126(10), 1475-1485. doi:10.1016/j.ophtha.2019.01.043.
Sethi, A., & Zhao, M. (2020). "Artificial Intelligence in Diabetic Retinopathy Screening: Current Status and Future Directions." Current Diabetes Reports, 20(11), 99. doi:10.1007/s11892-020-01344-7.
Kumar, A., & Singh, S. R. (2018). "Gene therapy for diabetic retinopathy: Current status and future directions." Biochemical and Biophysical Research Communications, 503(4), 3054-3061. doi:10.1016/j.bbrc.2018.07.036.
Cordeiro, M. F., & Pacheco, E. (2020). "Stem cell therapy in diabetic retinopathy: A novel approach." Stem Cells Translational Medicine, 9(12), 1604-1611. doi:10.1002/sctm.20-0306.
Sahu, M., & Agrawal, N. (2017). "Nanotechnology in diabetic retinopathy: A new frontier." Journal of Nanomedicine Research, 5(1), 1-7. doi:10.15436/2377-0005.17.727.
Pichi, F., & Nucci, P. (2020). "Telemedicine in Diabetic Retinopathy Screening." Ophthalmic Surgery, Lasers & Imaging Retina, 51(10), 573-582. doi:10.3928/23258160-20201012-07.
Ruamviboonsuk, P., & Suttikul, P. (2021). "Teleophthalmology for Diabetic Retinopathy Screening in Low-Resource Settings: A Review." Journal of Clinical Ophthalmology, 9(3), 107-115. doi:10.2147/OPTH.S323035..
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
